E
Qualigen Therapeutics, Inc. QLGN
$3.01 -$0.03-0.99%
Recommendation
Sell
Prev Close
$3.04
Volume
7,039
Avg Vol (90D)
59,266
Market Cap
$2.24M
Dividend & Yield
--
52-Week Range
$2.96 - $29.44
P/E (TTM)
--
EPS (TTM)
-$56.15
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
E+
Very Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Very Weak
Total Return Index
Very Weak
Volatility Index
Very Weak
Dividend Index
--
Headlines
Short Interest in Qualigen Therapeutics, Inc. (NASDAQ:QLGN) Expands By 49.4%
2/16/2025 - Ticker Report
Qualigen Therapeutics to participate in next funding round for NanoSynex
1/28/2025 - The Fly
Qualigen to participate in next funding round for NanoSynex
1/28/2025 - Globe Newswire
Qualigen Therapeutics (NASDAQ:QLGN) Trading Down 5.2% - Should You Sell?
1/10/2025 - Ticker Report
Qualigen Therapeutics regains compliance with Nasdaq's listing requirements
12/5/2024 - Seeking Alpha - Healthcare
Qualigen Therapeutics regains compliance with Nasdaq's min bid price
12/5/2024 - The Fly
Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement ...
12/5/2024 - GuruFocus
Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement
12/5/2024 - Globe Newswire
Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
11/25/2024 - Globe Newswire
Qualigen Therapeutics announces $4.5M private placement of convertible preferred shares
11/19/2024 - Seeking Alpha - Healthcare
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
11/19/2024 - GuruFocus
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
11/19/2024 - Globe Newswire
Qualigen Therapeutics Appoints Graydon Bensler to Board
11/13/2024 - TipRanks Financial Blog
Qualigen Therapeutics trading halted, news pending
11/5/2024 - TipRanks Financial Blog
Qualigen Therapeutics trading halted, news pending
11/5/2024 - The Fly
Qualigen Therapeutics Announces 1-for-50 Reverse Stock Split
11/1/2024 - TipRanks Financial Blog
Qualigen Therapeutics to implement 1-for-50 reverse stock split
11/1/2024 - The Fly
Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024
11/1/2024 - Globe Newswire
Qualigen Therapeutics announces CEO and CFO retirements
10/24/2024 - Seeking Alpha - Healthcare
Qualigen Therapeutics announces CEO and CFO retirements
10/24/2024 - SeekingAlpha.com: All News
Qualigen Therapeutics files to sell 14M shares of common stock
10/24/2024 - TipRanks Financial Blog
Qualigen Therapeutics files to sell 14M shares of common stock
10/24/2024 - The Fly
Qualigen Therapeutics Board Experiences Key Changes
10/9/2024 - TipRanks Financial Blog
Qualigen Therapeutics Announces Executive Shakeup and Board Revamp
9/26/2024 - TipRanks Financial Blog
Qualigen Therapeutics announces management changes
9/26/2024 - SeekingAlpha.com: All News
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$6.70M
EBIT (TTM)
-$6.71M
Net Income (TTM)
-$7.85M
Balance Sheet
Total Assets (Q)
$2.31M
Total Debt (Q)
$1.43M
Total Liabilities (Q)
$4.45M
Book Value Per Share (Q)
-$3.90
Cash Flow
Cash from Operations (TTM)
-$9.73M
Cash from Investing (TTM)
-$664.60K
Cash from Financing (TTM)
$4.83M
Net Change in Cash (TTM)
-$5.56M
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Apr 7 and 11 (est)
Price History
Loading...
Beta
1.16
7-Day Total Return
-2.90%
30-Day Total Return
-3.53%
60-Day Total Return
-22.82%
90-Day Total Return
-42.67%
Year to Date Total Return
-28.36%
1-Year Total Return
-85.13%
2-Year Total Return
-94.16%
3-Year Total Return
-98.91%
5-Year Total Return
--
52-week Low
Jan 29, 2025 - $2.96
52-week High
Jul 12, 2024 - $29.44
Valuation
Market Cap
$2.24M - Nano Cap
Enterprise Value
$3.28M
Price/Sales (TTM)
--
Price/Book (Q)
-0.78
Dividends and Shares
Shares Outstanding
387.90K
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.qlgntx.com
Phone Number
760 452 8111
Address
5857 Owens Avenue
Carlsbad, CA 92008
Country
United States
Year Founded
1996
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The... more
NASDAQ 03/12/2025 3:59PM Eastern Quotes delayed
Weiss Ratings